{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:56:18Z","timestamp":1787896578007,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Servier Hellas Pharmaceuticals Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40256-017-0232-5","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T07:19:24Z","timestamp":1493709564000},"page":"391-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril\/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice"],"prefix":"10.1007","volume":"17","author":[{"given":"Charalampos I.","family":"Liakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios T.","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"issue":"7","key":"232_CR1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M, et al. Task Force Members. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281\u2013357.","journal-title":"J Hypertens."},{"key":"232_CR2","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/01.hjh.0000187261.40190.2e","volume":"23","author":"BL Wijk Van","year":"2005","unstructured":"Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens. 2005;23:2101\u20137.","journal-title":"J Hypertens."},{"key":"232_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Arshad S, Poulter NR. Compliance, safety and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55:399\u2013407.","journal-title":"Hypertension."},{"key":"232_CR4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","volume":"23","author":"AJ Claxton","year":"2001","unstructured":"Claxton AJ, Cramer J, Pierce C. A systematic review of the association between dose regimens and medication compliance. Clin Ther. 2001;23:1296\u2013310.","journal-title":"Clin Ther."},{"key":"232_CR5","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht310.P4876","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. Task Force Members. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949\u20133003.","journal-title":"Eur Heart J."},{"issue":"20","key":"232_CR6","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA."},{"key":"232_CR7","doi-asserted-by":"crossref","unstructured":"ISPE. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf. 2008;17(2):200\u20138.","DOI":"10.1002\/pds.1471"},{"key":"232_CR8","unstructured":"International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonized tripartite guideline: guideline for good clinical practice. J Postgrad Med. 2001;47(1):45\u201350."},{"key":"232_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67\u201374.","journal-title":"Med Care."},{"key":"232_CR10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1369-7625.2011.00679.x","volume":"15","author":"C Stavropoulou","year":"2012","unstructured":"Stavropoulou C. Perceived information needs and non-adherence: evidence from Greek patients with hypertension. Health Expect. 2012;15:187\u201396.","journal-title":"Health Expect."},{"key":"232_CR11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/1470320315589272","volume":"16","author":"A Manolis","year":"2015","unstructured":"Manolis A, Grammatikou V, Kallistratos M, Zarifis J, Tsioufis K. Blood pressure reduction and control with fixed-dose combination perindopril\/amlodipine: a Pan-Hellenic prospective observational study. J Renin Angiotensin Aldosterone Syst. 2015;16:930\u20135.","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"232_CR12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1080\/03007995.2016.1193481","volume":"32","author":"C Vlachopoulos","year":"2016","unstructured":"Vlachopoulos C, Grammatikou V, Kallistratos M, Karagiannis A. Effectiveness of perindopril\/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study. Curr Med Res Opin. 2016;32:1605\u201310.","journal-title":"Curr Med Res Opin."},{"key":"232_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03256570","volume":"9","author":"VK Bahl","year":"2009","unstructured":"Bahl VK, Jadhav UM, Thacker HP. Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study. Am J Cardiovasc Drugs. 2009;9:135\u201342.","journal-title":"Am J Cardiovasc Drugs."},{"key":"232_CR14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40256-015-0144-1","volume":"15","author":"M Shirley","year":"2015","unstructured":"Shirley M, McCormack PL. Perindopril\/amlodipine (Prestalia\u00ae): a review in hypertension. Am J Cardiovasc Drugs. 2015;15:363\u201370.","journal-title":"Am J Cardiovasc Drugs."},{"key":"232_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/jhh.2008.157","volume":"23","author":"A Sierra de la","year":"2009","unstructured":"de la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens. 2009;23:503\u201311.","journal-title":"J Hum Hypertens."},{"key":"232_CR16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1751-7176.2009.00138.x","volume":"11","author":"WJ Elliott","year":"2009","unstructured":"Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich). 2009;11:376\u201382.","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"232_CR17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.clinthera.2007.05.010","volume":"29","author":"V Fung","year":"2007","unstructured":"Fung V, Huanq J, Brand R, Newhouse JP, Hsu J. Hypertension treatment in a Medicare population: adherence and systolic blood pressure control. Clin Ther. 2007;29:972\u201384.","journal-title":"Clin Ther."},{"key":"232_CR18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","volume":"120","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli F. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120:713\u20139.","journal-title":"Am J Med."},{"key":"232_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"A Gupta","year":"2010","unstructured":"Gupta A, Arshad S, Poulter N. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55:399\u2013407.","journal-title":"Hypertension."},{"key":"232_CR20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40261-016-0404-0","volume":"36","author":"K Hatalova","year":"2016","unstructured":"Hatalova K, Pella D, Sidlo R, Hatala R. Switching from a free association of perindopril\/amlodipine to a fixed-dose combination: increased antihypertensive efficacy and tolerability. Clin Drug Investig. 2016;36:591\u20138.","journal-title":"Clin Drug Investig."},{"key":"232_CR21","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1185\/03007990802576302","volume":"24","author":"R Ferrari","year":"2008","unstructured":"Ferrari R. Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril\/amlodipine. Curr Med Res Opin. 2008;24:3543\u201357.","journal-title":"Curr Med Res Opin."},{"key":"232_CR22","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"KM Fox","year":"2003","unstructured":"Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782\u20138.","journal-title":"Lancet."},{"key":"232_CR23","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s12325-016-0392-8","volume":"33","author":"T Forster","year":"2016","unstructured":"Forster T, D\u00e9zsi CA. Short-term cardioprotective effects of the original perindopril\/amlodipine fixed-dose combination in patients with stable coronary artery disease: results of the PAPA-CAD Study. Adv Ther. 2016;33:1771\u201381.","journal-title":"Adv Ther."},{"key":"232_CR24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40261-016-0431-x","volume":"36","author":"Z N\u00e1dh\u00e1zi","year":"2016","unstructured":"N\u00e1dh\u00e1zi Z, D\u00e9zsi CA. The results of ACES (Antihypertensive Combinations\u2019 Long Term Efficacy Comparing Study): analysis of metabolic effects of antihypertensive combination therapies. Clin Drug Investig. 2016;36:819\u201327.","journal-title":"Clin Drug Investig."},{"key":"232_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40256-014-0067-2","volume":"14","author":"T\u00f3th K; PIANIST Investigators","year":"2014","unstructured":"T\u00f3th K; PIANIST Investigators. Antihypertensive efficacy of triple combination perindopril\/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients). Am J Cardiovasc Drugs. 2014;14:137\u201345.","journal-title":"Am J Cardiovasc Drugs."},{"key":"232_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40256-016-0175-2","volume":"16","author":"ME Bertrand","year":"2016","unstructured":"Bertrand ME, Vlachopoulos C, Mourad JJ. Triple combination therapy for global cardiovascular risk: atorvastatin, perindopril, and amlodipine. Am J Cardiovasc Drugs. 2016;16:241\u201353.","journal-title":"Am J Cardiovasc Drugs."},{"key":"232_CR27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehp508","volume":"31","author":"CB Granger","year":"2010","unstructured":"Granger CB, Gersh BJ. Clinical trials and registries in cardiovascular disease: competitive or complementary? Eur Heart J. 2010;31:520\u20131.","journal-title":"Eur Heart J."},{"key":"232_CR28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348\u201354.","journal-title":"J Clin Hypertens (Greenwich)."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-017-0232-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0232-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0232-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T19:20:28Z","timestamp":1505157628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-017-0232-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1007\/s40256-017-0232-5","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]}}}